| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ethanol binding | 8.12e-09 | 6 | 98 | 4 | GO:0035276 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 5.38e-06 | 24 | 98 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 7.51e-06 | 26 | 98 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.10e-05 | 102 | 98 | 6 | GO:0043178 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.36e-05 | 30 | 98 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.87e-05 | 18 | 98 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.29e-04 | 227 | 98 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.44e-04 | 28 | 98 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | NAD binding | 4.58e-04 | 73 | 98 | 4 | GO:0051287 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 7.89e-04 | 37 | 98 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | hemoglobin binding | 1.27e-03 | 11 | 98 | 2 | GO:0030492 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 1.01e-07 | 3 | 97 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 1.00e-06 | 5 | 97 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.04e-06 | 17 | 97 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.20e-06 | 40 | 97 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.34e-06 | 18 | 97 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 3.80e-06 | 23 | 97 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 3.93e-06 | 89 | 97 | 6 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 5.40e-06 | 94 | 97 | 6 | GO:0016101 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.02e-05 | 105 | 97 | 6 | GO:0006721 | |
| GeneOntologyBiologicalProcess | mucociliary clearance | 2.79e-05 | 13 | 97 | 3 | GO:0120197 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 6.12e-05 | 144 | 97 | 6 | GO:0006720 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 6.54e-05 | 17 | 97 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 7.02e-05 | 47 | 97 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | cerebrospinal fluid circulation | 1.08e-04 | 20 | 97 | 3 | GO:0090660 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 1.13e-04 | 53 | 97 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | diacylglycerol metabolic process | 3.03e-04 | 28 | 97 | 3 | GO:0046339 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 3.90e-04 | 73 | 97 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | aldehyde biosynthetic process | 4.12e-04 | 31 | 97 | 3 | GO:0046184 | |
| MousePheno | abnormal ethanol metabolism | 1.72e-08 | 6 | 83 | 4 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 3.99e-08 | 7 | 83 | 4 | MP:0005444 | |
| MousePheno | abnormal vitamin metabolism | 1.50e-06 | 15 | 83 | 4 | MP:0013244 | |
| MousePheno | abnormal vitamin or vitamin cofactor metabolism | 1.50e-06 | 15 | 83 | 4 | MP:0013274 | |
| MousePheno | abnormal vitamin A metabolism | 1.50e-06 | 15 | 83 | 4 | MP:0011233 | |
| MousePheno | enhanced behavioral response to alcohol | 1.07e-04 | 16 | 83 | 3 | MP:0009751 | |
| Domain | ADH_N | 1.28e-08 | 16 | 95 | 5 | PF08240 | |
| Domain | ADH_N | 1.28e-08 | 16 | 95 | 5 | IPR013154 | |
| Domain | - | 2.49e-08 | 18 | 95 | 5 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 3.36e-08 | 19 | 95 | 5 | PF00107 | |
| Domain | ADH_SF_Zn-type | 3.36e-08 | 19 | 95 | 5 | IPR002085 | |
| Domain | ADH_C | 3.36e-08 | 19 | 95 | 5 | IPR013149 | |
| Domain | ADH_Zn_CS | 4.33e-08 | 8 | 95 | 4 | IPR002328 | |
| Domain | ADH_ZINC | 4.33e-08 | 8 | 95 | 4 | PS00059 | |
| Domain | GroES-like | 1.21e-07 | 24 | 95 | 5 | IPR011032 | |
| Domain | PKS_ER | 1.09e-06 | 16 | 95 | 4 | SM00829 | |
| Domain | PKS_ER | 1.09e-06 | 16 | 95 | 4 | IPR020843 | |
| Domain | DHC_N1 | 7.01e-06 | 8 | 95 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.01e-06 | 8 | 95 | 3 | IPR013594 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.46e-05 | 14 | 95 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.46e-05 | 14 | 95 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.46e-05 | 14 | 95 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.46e-05 | 14 | 95 | 3 | PF08393 | |
| Domain | MT | 4.46e-05 | 14 | 95 | 3 | PF12777 | |
| Domain | AAA_8 | 4.46e-05 | 14 | 95 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 4.46e-05 | 14 | 95 | 3 | IPR011704 | |
| Domain | AAA_5 | 4.46e-05 | 14 | 95 | 3 | PF07728 | |
| Domain | DHC_fam | 5.55e-05 | 15 | 95 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 5.55e-05 | 15 | 95 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 5.55e-05 | 15 | 95 | 3 | PF03028 | |
| Domain | I_LWEQ | 1.53e-04 | 4 | 95 | 2 | PF01608 | |
| Domain | ILWEQ_dom | 1.53e-04 | 4 | 95 | 2 | IPR002558 | |
| Domain | I_LWEQ | 1.53e-04 | 4 | 95 | 2 | PS50945 | |
| Domain | ILWEQ | 1.53e-04 | 4 | 95 | 2 | SM00307 | |
| Domain | ILWEQ | 1.53e-04 | 4 | 95 | 2 | PD011820 | |
| Domain | - | 1.53e-04 | 4 | 95 | 2 | 1.20.1410.10 | |
| Domain | Pentatricopeptide_repeat | 2.10e-04 | 23 | 95 | 3 | IPR002885 | |
| Domain | BRK | 3.79e-04 | 6 | 95 | 2 | SM00592 | |
| Domain | Surp | 3.79e-04 | 6 | 95 | 2 | PF01805 | |
| Domain | SWAP | 3.79e-04 | 6 | 95 | 2 | SM00648 | |
| Domain | SURP | 3.79e-04 | 6 | 95 | 2 | PS50128 | |
| Domain | BRK_domain | 3.79e-04 | 6 | 95 | 2 | IPR006576 | |
| Domain | Surp | 3.79e-04 | 6 | 95 | 2 | IPR000061 | |
| Domain | BRK | 3.79e-04 | 6 | 95 | 2 | PF07533 | |
| Domain | CHROMO_1 | 3.81e-04 | 28 | 95 | 3 | PS00598 | |
| Domain | CHROMO_2 | 3.81e-04 | 28 | 95 | 3 | PS50013 | |
| Domain | Chromodomain-like | 5.68e-04 | 32 | 95 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 6.23e-04 | 33 | 95 | 3 | IPR000953 | |
| Domain | CHROMO | 6.23e-04 | 33 | 95 | 3 | SM00298 | |
| Domain | AAA+_ATPase | 8.44e-04 | 144 | 95 | 5 | IPR003593 | |
| Domain | AAA | 8.44e-04 | 144 | 95 | 5 | SM00382 | |
| Domain | TPR-like_helical_dom | 1.22e-03 | 233 | 95 | 6 | IPR011990 | |
| Domain | - | 1.72e-03 | 169 | 95 | 5 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 1.90e-03 | 173 | 95 | 5 | IPR016040 | |
| Domain | Calpain_domain_III | 1.93e-03 | 13 | 95 | 2 | IPR022682 | |
| Domain | Calpain_III | 1.93e-03 | 13 | 95 | 2 | PF01067 | |
| Domain | Calpain_cysteine_protease | 2.24e-03 | 14 | 95 | 2 | IPR022684 | |
| Domain | CysPc | 2.57e-03 | 15 | 95 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 2.57e-03 | 15 | 95 | 2 | IPR001300 | |
| Domain | Peptidase_C2 | 2.57e-03 | 15 | 95 | 2 | PF00648 | |
| Domain | CALPAIN_CAT | 2.57e-03 | 15 | 95 | 2 | PS50203 | |
| Domain | GRAM | 2.93e-03 | 16 | 95 | 2 | SM00568 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 4.14e-03 | 19 | 95 | 2 | IPR006553 | |
| Domain | LRR_CC | 4.14e-03 | 19 | 95 | 2 | SM00367 | |
| Domain | CH | 4.43e-03 | 65 | 95 | 3 | SM00033 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 1.08e-07 | 10 | 69 | 4 | MM15833 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.69e-07 | 11 | 69 | 4 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 2.53e-07 | 12 | 69 | 4 | M14663 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 6.89e-07 | 15 | 69 | 4 | M39717 | |
| Pathway | REACTOME_ABACAVIR_ADME | 6.18e-06 | 8 | 69 | 3 | MM14869 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 1.58e-05 | 110 | 69 | 6 | MM16642 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 5.11e-05 | 42 | 69 | 4 | M16743 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 5.11e-05 | 42 | 69 | 4 | M699 | |
| Pathway | PID_AR_PATHWAY | 2.22e-04 | 61 | 69 | 4 | M58 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 2.37e-04 | 62 | 69 | 4 | M11521 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.68e-04 | 64 | 69 | 4 | M9488 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 3.37e-04 | 28 | 69 | 3 | MM15188 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.78e-04 | 70 | 69 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.21e-04 | 72 | 69 | 4 | M9257 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 4.57e-04 | 31 | 69 | 3 | M39714 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B AARS1 COPB1 PMPCB NOC2L U2SURP CAPN1 RANBP9 HIP1R CHD8 RBM28 RRBP1 ADAR LRPPRC PDIA6 SUGP2 TRIM28 MKI67 PRMT3 PRKDC PLEC SNRPA1 WDR13 DYNC1H1 | 4.37e-13 | 1353 | 99 | 24 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B COPB1 NOC2L UGGT1 U2SURP RBM28 RRBP1 ADAR KRT80 LRPPRC PDIA6 SUGP2 TRIM28 MKI67 CSTF3 PRKDC PLEC SNRPA1 SPEN DYNC1H1 | 9.50e-12 | 1024 | 99 | 20 | 24711643 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SLC25A24 PDS5B AARS1 DNAH10 COPB1 PMPCB NOC2L UGGT1 U2SURP RRBP1 ADAR LRPPRC PDIA6 TRIM28 MKI67 CSTF3 TLN2 PRMT3 PRKDC MYO18B SNRPA1 SPEN DYNC1H1 | 9.92e-12 | 1425 | 99 | 23 | 30948266 |
| Pubmed | PDS5B AARS1 COPB1 NOC2L UGGT1 U2SURP CAPN1 CHD8 RBM28 LRPPRC SUGP2 MKI67 PRKDC PLEC SPEN DYNC1H1 | 5.32e-11 | 653 | 99 | 16 | 22586326 | |
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 2893758 | ||
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 9733106 | ||
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 9202249 | ||
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 9241435 | ||
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 9002638 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 2.07e-10 | 90 | 99 | 8 | 35654790 | |
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 11836246 | ||
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 8621625 | ||
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 7738026 | ||
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 8892527 | ||
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 7026729 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 3.08e-10 | 5 | 99 | 4 | 19193628 | |
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 3.08e-10 | 5 | 99 | 4 | 22079585 | |
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 10358022 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M SLC25A24 PMPCB NOC2L UGGT1 CAPN1 RBM28 RRBP1 ADAR KRT80 KNOP1 LRPPRC TRIM28 MKI67 NAV1 PRKDC PLEC SNRPA1 SPEN DYNC1H1 | 3.54e-10 | 1257 | 99 | 20 | 36526897 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PDS5B ESS2 COPB1 NOC2L RPS6KA3 U2SURP CHD8 RBM28 RRBP1 ADAR KNOP1 LRPPRC TRIM28 MKI67 CHD6 PRMT3 PRKDC PLEC SNRPA1 DYNC1H1 | 8.02e-10 | 1318 | 99 | 20 | 30463901 |
| Pubmed | 9.22e-10 | 6 | 99 | 4 | 17257171 | ||
| Pubmed | 9.22e-10 | 6 | 99 | 4 | 12027900 | ||
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 9.22e-10 | 6 | 99 | 4 | 9982 | |
| Pubmed | 9.22e-10 | 6 | 99 | 4 | 518534 | ||
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 9.22e-10 | 6 | 99 | 4 | 17185388 | |
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 16685648 | ||
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 2.15e-09 | 7 | 99 | 4 | 23468174 | |
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 16047160 | ||
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 11784316 | ||
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 18331377 | ||
| Pubmed | PDS5B COPB1 RANBP9 HIP1R ADAR LRPPRC MKI67 PRKDC PLEC DYNC1H1 | 6.13e-09 | 272 | 99 | 10 | 31010829 | |
| Pubmed | AARS1 U2SURP RANBP9 RBM28 RRBP1 ADAR LRPPRC PDIA6 TRIM28 PRMT3 PRKDC PLEC SNRPA1 | 6.15e-09 | 551 | 99 | 13 | 34728620 | |
| Pubmed | 7.70e-09 | 9 | 99 | 4 | 11747070 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SLC25A24 PDS5B U2SURP TNRC6B ADAR KNOP1 LRPPRC PDIA6 SUGP2 TRIM28 CSTF3 CHD6 PRKDC PLEC SNRPA1 SPEN DYNC1H1 | 1.06e-08 | 1082 | 99 | 17 | 38697112 |
| Pubmed | A2M NOC2L U2SURP RBM28 RRBP1 ADAR KNOP1 SUGP2 TRIM28 MKI67 PRKDC DYNC1H1 | 1.39e-08 | 483 | 99 | 12 | 36912080 | |
| Pubmed | RPS6KA3 CHD8 RRBP1 ADAR PDIA6 TRIM28 MKI67 NAV2 TLN2 MTCL1 SNRPA1 SPEN | 2.18e-08 | 503 | 99 | 12 | 16964243 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 11960985 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 2474823 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 2.24e-08 | 3 | 99 | 3 | 23772048 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 2.24e-08 | 3 | 99 | 3 | 24787690 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 3011597 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 6756216 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 37806378 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 7840644 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 2.24e-08 | 3 | 99 | 3 | 15670660 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 2.24e-08 | 3 | 99 | 3 | 33586683 | |
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 2.24e-08 | 3 | 99 | 3 | 3157987 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 2169444 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 2.24e-08 | 3 | 99 | 3 | 8486690 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 24722735 | ||
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 2.24e-08 | 3 | 99 | 3 | 16801720 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 2.24e-08 | 3 | 99 | 3 | 10424757 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 2347582 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 2.24e-08 | 3 | 99 | 3 | 7748347 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 3006456 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 2.24e-08 | 3 | 99 | 3 | 9145544 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 2.24e-08 | 3 | 99 | 3 | 6816803 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 2.24e-08 | 3 | 99 | 3 | 15554233 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 35354963 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 6370228 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 2935875 | ||
| Pubmed | 3.00e-08 | 12 | 99 | 4 | 12128098 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M SLC25A24 AARS1 COPB1 UGGT1 TNRC6B KRT80 LRPPRC PDIA6 TRIM28 PRKDC PLEC DYNC1H1 | 4.06e-08 | 647 | 99 | 13 | 26618866 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOC2L U2SURP RBM28 RRBP1 ADAR LRPPRC SUGP2 TRIM28 RAVER2 CSTF3 PRKDC SNRPA1 SPEN DYNC1H1 | 7.21e-08 | 807 | 99 | 14 | 22681889 |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 8.23e-08 | 15 | 99 | 4 | 9726281 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B U2SURP CHD8 RBM28 RRBP1 ADAR KNOP1 IFRD1 SUGP2 TRIM28 MKI67 CSTF3 PRKDC SNRPA1 SPEN | 8.46e-08 | 954 | 99 | 15 | 36373674 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 8.71e-08 | 271 | 99 | 9 | 32433965 | |
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 8813054 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 12631290 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 11893554 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 29663519 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 12851412 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 36224745 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 19618839 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 8.93e-08 | 4 | 99 | 3 | 3996732 | |
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 10880953 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 15193143 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 19687126 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 15765518 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOC2L U2SURP RBM28 ADAR KRT80 KNOP1 SUGP2 TRIM28 MKI67 PRKDC SNRPA1 SPEN | 1.61e-07 | 605 | 99 | 12 | 28977666 |
| Pubmed | A2M SLC25A24 COPB1 UGGT1 ADAR FBXL5 LRPPRC PDIA6 TRIM28 LNPEP SEL1L3 PRKDC | 1.85e-07 | 613 | 99 | 12 | 22268729 | |
| Pubmed | 1.95e-07 | 298 | 99 | 9 | 30737378 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 2.12e-07 | 217 | 99 | 8 | 31685992 | |
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 19861527 | ||
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 1316195 | ||
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 20700531 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 2.44e-07 | 221 | 99 | 8 | 29991511 | |
| Pubmed | PDS5B TNRC6B FHIP2A SUGP2 SEL1L3 NAV1 CHD6 MTCL1 SPEN DYNC1H1 | 2.66e-07 | 407 | 99 | 10 | 12693553 | |
| Pubmed | 2.80e-07 | 225 | 99 | 8 | 12168954 | ||
| Pubmed | COPB1 ADAR LRPPRC PDIA6 SUGP2 TRIM28 CSTF3 PRMT3 PRKDC PLEC SNRPA1 DYNC1H1 | 2.83e-07 | 638 | 99 | 12 | 33239621 | |
| Pubmed | 4.45e-07 | 6 | 99 | 3 | 26807981 | ||
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 4.45e-07 | 6 | 99 | 3 | 16121213 | |
| Pubmed | 4.65e-07 | 101 | 99 | 6 | 26949739 | ||
| Interaction | H3C1 interactions | RNASEH2B PDS5B RPS6KA3 U2SURP CAPN1 CHD8 RBM28 RRBP1 KNOP1 TRIM28 MSL3 MKI67 NAV2 CSTF3 PRKDC SPEN DNAH9 DYNC1H1 WWC1 | 6.85e-08 | 901 | 99 | 19 | int:H3C1 |
| Interaction | USP53 interactions | 4.00e-07 | 138 | 99 | 8 | int:USP53 | |
| Interaction | SIRT7 interactions | PDS5B AARS1 COPB1 NOC2L UGGT1 U2SURP CAPN1 CHD8 RBM28 LRPPRC SUGP2 MKI67 PRKDC PLEC SPEN DYNC1H1 | 6.57e-07 | 744 | 99 | 16 | int:SIRT7 |
| Interaction | BIRC3 interactions | SLC25A24 PDS5B AARS1 DNAH10 COPB1 PMPCB NOC2L UGGT1 U2SURP RRBP1 ADAR LRPPRC PDIA6 TRIM28 MKI67 CSTF3 TLN2 PRKDC SNRPA1 SPEN DYNC1H1 | 1.63e-06 | 1334 | 99 | 21 | int:BIRC3 |
| Interaction | ITGB3 interactions | 1.94e-06 | 170 | 99 | 8 | int:ITGB3 | |
| Interaction | CUL7 interactions | NOC2L U2SURP CFAP43 RRBP1 ADAR LRPPRC PDIA6 TRIM28 MKI67 MROH7 CSTF3 PRKDC PLEC SNRPA1 SPEN DYNC1H1 | 3.44e-06 | 845 | 99 | 16 | int:CUL7 |
| Interaction | MECP2 interactions | SLC25A24 PDS5B NOC2L U2SURP TNRC6B RBM28 ADAR KNOP1 LRPPRC PDIA6 SUGP2 TRIM28 MKI67 CSTF3 CHD6 PRKDC PLEC SNRPA1 SPEN DYNC1H1 | 3.69e-06 | 1287 | 99 | 20 | int:MECP2 |
| Interaction | ADARB1 interactions | NOC2L U2SURP CHD8 RBM28 RRBP1 ADAR KNOP1 LRPPRC SUGP2 MKI67 PLEC SNRPA1 | 4.97e-06 | 489 | 99 | 12 | int:ADARB1 |
| Interaction | TEDC2 interactions | 8.03e-06 | 206 | 99 | 8 | int:TEDC2 | |
| Interaction | NR2C2 interactions | PDS5B ESS2 COPB1 NOC2L RPS6KA3 U2SURP CHD8 RBM28 RRBP1 ADAR KNOP1 LRPPRC TRIM28 MKI67 CHD6 PRMT3 PRKDC PLEC SNRPA1 DYNC1H1 | 1.33e-05 | 1403 | 99 | 20 | int:NR2C2 |
| Interaction | DNAH5 interactions | 1.56e-05 | 31 | 99 | 4 | int:DNAH5 | |
| Interaction | PRC1 interactions | PDS5B AARS1 COPB1 NOC2L RBM28 ADAR LRPPRC TRIM28 MKI67 CDK5RAP2 PRKDC MTCL1 FBXO39 PLEC SPEN DYNC1H1 | 2.01e-05 | 973 | 99 | 16 | int:PRC1 |
| Interaction | CIT interactions | PDS5B AARS1 COPB1 NOC2L CHD8 CFAP43 RBM28 ADAR LRPPRC PDIA6 SUGP2 TRIM28 MKI67 CSTF3 CDK5RAP2 PRKDC PLEC GRAMD1C DYNC1H1 WWC1 | 2.14e-05 | 1450 | 99 | 20 | int:CIT |
| Interaction | CDKL2 interactions | 2.60e-05 | 71 | 99 | 5 | int:CDKL2 | |
| Interaction | ADH1B interactions | 3.17e-05 | 13 | 99 | 3 | int:ADH1B | |
| Interaction | USP36 interactions | A2M NOC2L U2SURP RBM28 RRBP1 ADAR KNOP1 SUGP2 TRIM28 MKI67 PRKDC DYNC1H1 | 3.73e-05 | 599 | 99 | 12 | int:USP36 |
| Interaction | PRMT1 interactions | PDS5B AARS1 U2SURP RANBP9 RBM28 RRBP1 ADAR LRPPRC PDIA6 TRIM28 ASXL3 PRMT3 PRKDC PLEC SNRPA1 | 4.63e-05 | 929 | 99 | 15 | int:PRMT1 |
| Interaction | SRPK2 interactions | ERN1 NOC2L U2SURP RBM28 ADAR KNOP1 OTOF MKI67 EPS8L3 MTCL1 MYO18B SPEN DNAH9 | 4.86e-05 | 717 | 99 | 13 | int:SRPK2 |
| Interaction | HNRNPA1 interactions | RPS6KA3 RANBP9 PARD3B ADAR KRT80 LRPPRC SUGP2 ASXL3 RAVER2 MKI67 CSTF3 PRMT3 PRKDC PLEC SNRPA1 | 5.62e-05 | 945 | 99 | 15 | int:HNRNPA1 |
| Interaction | EED interactions | PDS5B AARS1 COPB1 NOC2L UGGT1 CAPN1 OBSCN RBM28 POLE3 ADAR LRPPRC PDIA6 TRIM28 PRKDC PLEC SNRPA1 SPEN HBE1 DYNC1H1 | 6.82e-05 | 1445 | 99 | 19 | int:EED |
| Interaction | CDC5L interactions | ESS2 COPB1 U2SURP HIP1R CHD8 CSTF3 TLN2 PRKDC MTCL1 PLEC SNRPA1 SPEN DYNC1H1 WWC1 | 7.32e-05 | 855 | 99 | 14 | int:CDC5L |
| Interaction | MIR138-2 interactions | 7.33e-05 | 88 | 99 | 5 | int:MIR138-2 | |
| Interaction | GSK3B interactions | AARS1 CAPN1 TNRC6B RBM28 RRBP1 TRIM28 MKI67 AKAP11 CHD6 PRMT3 PRKDC MTCL1 PLEC WWC1 | 8.60e-05 | 868 | 99 | 14 | int:GSK3B |
| Interaction | CCDC8 interactions | COPB1 NOC2L UGGT1 KRT80 LRPPRC PDIA6 SUGP2 TRIM28 MKI67 PRKDC PLEC DYNC1H1 | 8.91e-05 | 656 | 99 | 12 | int:CCDC8 |
| Interaction | BMI1 interactions | TNRC6B PABPC4L RRBP1 ADAR LRPPRC SUGP2 TRIM28 MKI67 PRKDC PLEC SPEN DYNC1H1 | 9.30e-05 | 659 | 99 | 12 | int:BMI1 |
| Interaction | GSK3A interactions | U2SURP TNRC6B RRBP1 SUGP2 TRIM28 AKAP11 PRMT3 PRKDC MTCL1 WWC1 | 9.50e-05 | 464 | 99 | 10 | int:GSK3A |
| Interaction | SMC5 interactions | PDS5B U2SURP CHD8 RBM28 RRBP1 ADAR KNOP1 IFRD1 SUGP2 TRIM28 MKI67 CSTF3 PRKDC SNRPA1 SPEN | 1.06e-04 | 1000 | 99 | 15 | int:SMC5 |
| Interaction | PPIA interactions | SLC25A24 U2SURP RANBP9 HIP1R TNRC6B CHD8 RRBP1 ADAR JAK2 SUGP2 MKI67 CSTF3 TLN2 DNAH9 | 1.09e-04 | 888 | 99 | 14 | int:PPIA |
| Interaction | VCAM1 interactions | AARS1 CAPN1 HIP1R LRPPRC TRIM28 PRKDC PLEC SNRPA1 HBE1 DYNC1H1 | 1.15e-04 | 475 | 99 | 10 | int:VCAM1 |
| Interaction | MEX3A interactions | 1.15e-04 | 384 | 99 | 9 | int:MEX3A | |
| Interaction | MIR21 interactions | 1.16e-04 | 97 | 99 | 5 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 1.16e-04 | 97 | 99 | 5 | int:MIRLET7F2 | |
| Interaction | MIR128-2 interactions | 1.28e-04 | 99 | 99 | 5 | int:MIR128-2 | |
| Interaction | OBSL1 interactions | PDS5B NOC2L U2SURP RBM28 ADAR PDIA6 SUGP2 TRIM28 MKI67 PRKDC PLEC SNRPA1 SPEN DYNC1H1 | 1.29e-04 | 902 | 99 | 14 | int:OBSL1 |
| Interaction | MIR19A interactions | 1.34e-04 | 100 | 99 | 5 | int:MIR19A | |
| Interaction | SKI interactions | 1.39e-04 | 160 | 99 | 6 | int:SKI | |
| Interaction | MIR15B interactions | 1.55e-04 | 103 | 99 | 5 | int:MIR15B | |
| Interaction | H2BC21 interactions | PDS5B NOC2L RPS6KA3 OBSCN CHD8 POLE3 OTOF MSL3 MKI67 AKAP11 PRKDC DYNC1H1 | 1.55e-04 | 696 | 99 | 12 | int:H2BC21 |
| Interaction | EPHA1 interactions | 1.61e-04 | 235 | 99 | 7 | int:EPHA1 | |
| Interaction | MIR19B1 interactions | 1.62e-04 | 104 | 99 | 5 | int:MIR19B1 | |
| Interaction | SOX2 interactions | A2M CAPN1 RANBP9 HIP1R PABPC4L CHD8 RBM28 ADAR SERPINA12 ADH7 SUGP2 TRIM28 MSL3 NAV2 AKAP11 CHD6 SNRPA1 SPEN | 1.76e-04 | 1422 | 99 | 18 | int:SOX2 |
| Interaction | FZR1 interactions | COPB1 NOC2L CAPN1 TNRC6B CHD8 RBM28 RRBP1 LRPPRC PDIA6 IFRD1 TRIM28 CSTF3 PRKDC MTCL1 SNRPA1 DAGLA | 1.81e-04 | 1172 | 99 | 16 | int:FZR1 |
| Interaction | HEATR6 interactions | 2.02e-04 | 109 | 99 | 5 | int:HEATR6 | |
| Interaction | LECT2 interactions | 2.16e-04 | 24 | 99 | 3 | int:LECT2 | |
| Interaction | PPP2R2B interactions | 2.23e-04 | 248 | 99 | 7 | int:PPP2R2B | |
| Interaction | ADH1A interactions | 2.37e-04 | 5 | 99 | 2 | int:ADH1A | |
| Interaction | AMBN interactions | 2.37e-04 | 5 | 99 | 2 | int:AMBN | |
| Interaction | MIRLET7I interactions | 2.48e-04 | 114 | 99 | 5 | int:MIRLET7I | |
| Interaction | AP2M1 interactions | RPS6KA3 TNRC6B CHD8 PKD1L3 KNOP1 C1orf226 TRIM28 AKAP11 PRKDC | 2.68e-04 | 430 | 99 | 9 | int:AP2M1 |
| Interaction | FOXP3 interactions | 2.77e-04 | 432 | 99 | 9 | int:FOXP3 | |
| Interaction | HDLBP interactions | A2M UGGT1 TNRC6B RBM28 RRBP1 ADAR KNOP1 ADH1B SUGP2 MKI67 MYH16 PRKDC DYNC1H1 | 2.79e-04 | 855 | 99 | 13 | int:HDLBP |
| Interaction | MIRLET7G interactions | 2.80e-04 | 117 | 99 | 5 | int:MIRLET7G | |
| Interaction | WDR5 interactions | PDS5B AARS1 COPB1 HIP1R CHD8 POLE3 RRBP1 LRPPRC PDIA6 TRIM28 ASXL3 PRKDC PLEC SNRPA1 DYNC1H1 | 3.01e-04 | 1101 | 99 | 15 | int:WDR5 |
| Interaction | KCNA3 interactions | COPB1 TNRC6B RRBP1 LRPPRC PDIA6 TRIM28 LRP2 CDK5RAP2 TLN2 PRKDC SNRPA1 SPEN DYNC1H1 | 3.34e-04 | 871 | 99 | 13 | int:KCNA3 |
| Interaction | CHD3 interactions | NOC2L U2SURP RBM28 ADAR KRT80 KNOP1 SUGP2 TRIM28 MKI67 CHD6 PRKDC SNRPA1 | 3.35e-04 | 757 | 99 | 12 | int:CHD3 |
| Interaction | AURKB interactions | AARS1 NOC2L RANBP9 RBM28 LRPPRC SUGP2 TRIM28 MKI67 CDK5RAP2 PRKDC PLEC DYNC1H1 | 3.51e-04 | 761 | 99 | 12 | int:AURKB |
| Interaction | ITGA4 interactions | AARS1 CAPN1 HIP1R LRPPRC TRIM28 PRKDC PLEC SNRPA1 HBE1 DYNC1H1 | 3.58e-04 | 547 | 99 | 10 | int:ITGA4 |
| Interaction | H3-4 interactions | 3.62e-04 | 448 | 99 | 9 | int:H3-4 | |
| Interaction | PHB1 interactions | SLC25A24 COPB1 PMPCB UGGT1 TNRC6B RRBP1 ADAR LRPPRC PDIA6 TRIM28 NMT2 PRKDC PLEC SNRPA1 DYNC1H1 | 3.72e-04 | 1123 | 99 | 15 | int:PHB1 |
| Interaction | COIL interactions | 3.84e-04 | 552 | 99 | 10 | int:COIL | |
| Interaction | DPP4 interactions | SLC25A24 LAMTOR2 NOC2L UGGT1 RBM28 PDIA6 LNPEP PRKDC DYNC1H1 | 3.92e-04 | 453 | 99 | 9 | int:DPP4 |
| Interaction | FOXL1 interactions | 4.15e-04 | 196 | 99 | 6 | int:FOXL1 | |
| Interaction | METTL14 interactions | 4.18e-04 | 558 | 99 | 10 | int:METTL14 | |
| Interaction | CCDC191 interactions | 4.94e-04 | 7 | 99 | 2 | int:CCDC191 | |
| Interaction | AP2B1 interactions | 5.06e-04 | 373 | 99 | 8 | int:AP2B1 | |
| Interaction | SLX4 interactions | 5.08e-04 | 572 | 99 | 10 | int:SLX4 | |
| Interaction | NUPR1 interactions | PDS5B NOC2L UGGT1 U2SURP ADAR KRT80 TRIM28 MKI67 CSTF3 PRKDC PLEC | 5.26e-04 | 683 | 99 | 11 | int:NUPR1 |
| Interaction | CCND1 interactions | 5.27e-04 | 286 | 99 | 7 | int:CCND1 | |
| Interaction | H2BC8 interactions | 5.36e-04 | 576 | 99 | 10 | int:H2BC8 | |
| Interaction | MIR429 interactions | 5.36e-04 | 76 | 99 | 4 | int:MIR429 | |
| Interaction | FOXB1 interactions | 5.41e-04 | 135 | 99 | 5 | int:FOXB1 | |
| Interaction | MIR92A1 interactions | 5.92e-04 | 78 | 99 | 4 | int:MIR92A1 | |
| Interaction | HCFC1 interactions | 6.08e-04 | 293 | 99 | 7 | int:HCFC1 | |
| Interaction | PTEN interactions | COPB1 NOC2L UGGT1 ADAR FBXL5 LRPPRC PDIA6 SUGP2 TRIM28 MKI67 PRKDC PLEC SNRPA1 | 6.14e-04 | 929 | 99 | 13 | int:PTEN |
| Interaction | MIR222 interactions | 6.21e-04 | 79 | 99 | 4 | int:MIR222 | |
| Interaction | MIR206 interactions | 6.21e-04 | 79 | 99 | 4 | int:MIR206 | |
| Interaction | CD80 interactions | 6.21e-04 | 79 | 99 | 4 | int:CD80 | |
| Interaction | CDCA5 interactions | 6.38e-04 | 140 | 99 | 5 | int:CDCA5 | |
| Interaction | PPA2 interactions | 6.38e-04 | 140 | 99 | 5 | int:PPA2 | |
| Interaction | ILF2 interactions | NOC2L RBM28 ADAR KNOP1 SUGP2 TRIM28 ASXL3 PRKDC SNRPA1 DYNC1H1 | 6.45e-04 | 590 | 99 | 10 | int:ILF2 |
| Interaction | AGR2 interactions | SLC25A24 AARS1 COPB1 UGGT1 CAPN1 CHD8 RRBP1 LRPPRC PDIA6 TRIM28 PRKDC PLEC DYNC1H1 | 6.45e-04 | 934 | 99 | 13 | int:AGR2 |
| Interaction | SLC15A1 interactions | 6.51e-04 | 80 | 99 | 4 | int:SLC15A1 | |
| Interaction | H2AX interactions | A2M RNASEH2B RPS6KA3 TP53I3 PABPC4L CHD8 PDIA6 TRIM28 MKI67 PRKDC | 6.71e-04 | 593 | 99 | 10 | int:H2AX |
| Interaction | CHD4 interactions | NOC2L U2SURP RBM28 RRBP1 ADAR KRT80 KNOP1 SUGP2 TRIM28 MKI67 PRKDC SNRPA1 SPEN | 6.71e-04 | 938 | 99 | 13 | int:CHD4 |
| Interaction | GRWD1 interactions | 6.77e-04 | 390 | 99 | 8 | int:GRWD1 | |
| Interaction | DLST interactions | 6.89e-04 | 490 | 99 | 9 | int:DLST | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 1.27e-06 | 37 | 99 | 4 | chr4q23 | |
| Cytoband | 4q23 | 1.08e-05 | 20 | 99 | 3 | 4q23 | |
| Cytoband | 1p13.3 | 4.60e-04 | 69 | 99 | 3 | 1p13.3 | |
| Cytoband | 3q13.31 | 6.13e-04 | 17 | 99 | 2 | 3q13.31 | |
| Cytoband | 2q14.3 | 9.41e-04 | 21 | 99 | 2 | 2q14.3 | |
| Cytoband | 8q24 | 1.68e-03 | 28 | 99 | 2 | 8q24 | |
| GeneFamily | Alcohol dehydrogenases | 9.89e-09 | 8 | 64 | 4 | 397 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.29e-05 | 181 | 64 | 6 | 694 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 9.38e-04 | 13 | 64 | 2 | 1146 | |
| GeneFamily | RNA binding motif containing | 9.39e-04 | 213 | 64 | 5 | 725 | |
| GeneFamily | C2 domain containing|Calpains | 1.26e-03 | 15 | 64 | 2 | 975 | |
| GeneFamily | Dyneins, axonemal | 1.62e-03 | 17 | 64 | 2 | 536 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.48e-03 | 21 | 64 | 2 | 558 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLC25A24 PDS5B RPS6KA3 U2SURP LRPPRC IFRD1 NMT2 FGF5 AKAP11 PRMT3 MTCL1 SPEN WWC1 ARHGAP19 | 4.09e-06 | 856 | 99 | 14 | M4500 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 4.96e-06 | 250 | 99 | 8 | M11318 | |
| Coexpression | ABRAMSON_INTERACT_WITH_AIRE | 2.31e-05 | 44 | 99 | 4 | M2536 | |
| Coexpression | BCAT_BILD_ET_AL_DN | 2.77e-05 | 46 | 99 | 4 | M2702 | |
| Coexpression | MISSIAGLIA_REGULATED_BY_METHYLATION_DN | 1.01e-04 | 122 | 99 | 5 | M6866 | |
| Coexpression | GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN | 1.08e-04 | 198 | 99 | 6 | M8169 | |
| Coexpression | GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.08e-04 | 198 | 99 | 6 | M5344 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN | 1.08e-04 | 198 | 99 | 6 | M5670 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP | 1.14e-04 | 200 | 99 | 6 | M4617 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 1.14e-04 | 200 | 99 | 6 | M4512 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | 1.14e-04 | 200 | 99 | 6 | M7143 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 1.14e-04 | 200 | 99 | 6 | M6044 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-09 | 184 | 99 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-09 | 184 | 99 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-09 | 184 | 99 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.30e-07 | 190 | 99 | 7 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.74e-07 | 195 | 99 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.74e-07 | 195 | 99 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.74e-07 | 195 | 99 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 186 | 99 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-06 | 186 | 99 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-06 | 191 | 99 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.50e-06 | 192 | 99 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.64e-06 | 193 | 99 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.07e-06 | 196 | 99 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.07e-06 | 196 | 99 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 5.07e-06 | 196 | 99 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.53e-06 | 199 | 99 | 6 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.53e-06 | 199 | 99 | 6 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Crh_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.05e-05 | 61 | 99 | 4 | 351078cb41e285af7e117820ee607d4c24332a9d | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Crh_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.05e-05 | 61 | 99 | 4 | aae9ba2240812258d1c9e0e443d4f817b4796131 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.21e-05 | 151 | 99 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Sparc-Astrocyte.Gja1.Sparc-Car2_(Car2)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 75 | 99 | 4 | 162b69b9934da4623ee378b0e8206c4e4917351b | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Sparc-Astrocyte.Gja1.Sparc-Car2_(Car2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 75 | 99 | 4 | 98807389b7735b90024ba5e71be60cf95416c077 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Sparc|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 75 | 99 | 4 | 15505f3e7a25b3ae51f0917335e92d6279e6d06d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-05 | 164 | 99 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 166 | 99 | 5 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 166 | 99 | 5 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-05 | 169 | 99 | 5 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-05 | 169 | 99 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.01e-05 | 171 | 99 | 5 | 04346d4eb726875e3537e215ea081a0318ca4ddd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 175 | 99 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.85e-05 | 178 | 99 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.98e-05 | 179 | 99 | 5 | a634ca46ffc394c5f5215fc5d8eae4a77819af9c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.98e-05 | 179 | 99 | 5 | 35f014b6e752626909d829c5ab9bb761c1f3e3dc | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 181 | 99 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 185 | 99 | 5 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.82e-05 | 185 | 99 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-05 | 187 | 99 | 5 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.29e-05 | 188 | 99 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 6.29e-05 | 188 | 99 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.29e-05 | 188 | 99 | 5 | 6f53bcd4caab2fc961af799039ea5c3ddae56781 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.44e-05 | 189 | 99 | 5 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-05 | 189 | 99 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | mild-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.44e-05 | 189 | 99 | 5 | db2097e6e165004d47ed504e115083a4e4f4b147 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 6.44e-05 | 189 | 99 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 190 | 99 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 190 | 99 | 5 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 190 | 99 | 5 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.77e-05 | 191 | 99 | 5 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.77e-05 | 191 | 99 | 5 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.77e-05 | 191 | 99 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.77e-05 | 191 | 99 | 5 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.77e-05 | 191 | 99 | 5 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 191 | 99 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.77e-05 | 191 | 99 | 5 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 6.77e-05 | 191 | 99 | 5 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.77e-05 | 191 | 99 | 5 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.77e-05 | 191 | 99 | 5 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | 6.94e-05 | 192 | 99 | 5 | 3d0240491296757b3125f6e861bbaca06bbc5068 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.94e-05 | 192 | 99 | 5 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | 6.94e-05 | 192 | 99 | 5 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.11e-05 | 193 | 99 | 5 | 227d82059a9f99937e0188ff57f2d0e485ebfe69 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.11e-05 | 193 | 99 | 5 | 38bb14df7f05c29565a1c7f175fafe636e543bf8 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.11e-05 | 193 | 99 | 5 | 3ba6d44248690b80f4caf791d463e60f1ab816c4 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.11e-05 | 193 | 99 | 5 | 7b4b0271e4fbece703876acb053ae236afb7cdba | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.11e-05 | 193 | 99 | 5 | ce3873ece35fd2155ea235cb3c8bcd235cc0ebde | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.11e-05 | 193 | 99 | 5 | 8f57b0473a2c2c07f83e5fe70f16862b1bb3b514 | |
| ToppCell | severe-Plasmablast|World / disease stage, cell group and cell class | 7.29e-05 | 194 | 99 | 5 | 49e8f90db571a89b8a26aef31fcacd66429fed11 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.29e-05 | 194 | 99 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-05 | 195 | 99 | 5 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | severe-Plasmablast|severe / disease stage, cell group and cell class | 7.47e-05 | 195 | 99 | 5 | e11616ad568e50e4c720b50b0c071f484c31d16b | |
| ToppCell | COVID-19_Severe-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 7.65e-05 | 196 | 99 | 5 | 16359a56297f0558fc93fa52563cce0c53def167 | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.65e-05 | 196 | 99 | 5 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.65e-05 | 196 | 99 | 5 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.65e-05 | 196 | 99 | 5 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.84e-05 | 197 | 99 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.84e-05 | 197 | 99 | 5 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.84e-05 | 197 | 99 | 5 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.84e-05 | 197 | 99 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.84e-05 | 197 | 99 | 5 | 1e63879633f20646e44873ae6b662f6faf4806fd | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.84e-05 | 197 | 99 | 5 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.84e-05 | 197 | 99 | 5 | b754fad4f3caae6de95df901fd96ea8697fe41b1 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.84e-05 | 197 | 99 | 5 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.84e-05 | 197 | 99 | 5 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | COVID-19_Severe-Neu_2|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 7.84e-05 | 197 | 99 | 5 | 945f19475905cdedf232315eea1076ca0b753b67 | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 8.03e-05 | 198 | 99 | 5 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 8.03e-05 | 198 | 99 | 5 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.03e-05 | 198 | 99 | 5 | e84c5f712e1dea548d0e2aba6625598f9671d3a0 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 8.03e-05 | 198 | 99 | 5 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | 8.22e-05 | 199 | 99 | 5 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 8.22e-05 | 199 | 99 | 5 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast|COVID-19_Mild / Disease, condition lineage and cell class | 8.22e-05 | 199 | 99 | 5 | 46f31aef26c3da7608082f750d743ad54adbc51a | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.41e-05 | 200 | 99 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | fee909730133ec9875e14f7deed2a351dd21dba4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | ea1325ca6039c6d2318b1ceb9d396399bb21b670 | |
| ToppCell | COVID_vent|World / Disease condition, Lineage, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | 1d88e5cc4534073f27a7562e1c4b884bd67f09d9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.74e-04 | 125 | 99 | 4 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| Computational | Genes in the cancer module 514. | 1.36e-07 | 10 | 56 | 4 | MODULE_514 | |
| Computational | Oxidoreductases. | 4.51e-06 | 22 | 56 | 4 | MODULE_373 | |
| Computational | Neighborhood of UBE2N | 1.30e-04 | 95 | 56 | 5 | MORF_UBE2N | |
| Computational | Neighborhood of BUB3 | 5.51e-04 | 277 | 56 | 7 | MORF_BUB3 | |
| Drug | hexa-2,4-dien-1-ol | 1.09e-09 | 12 | 99 | 5 | CID000008104 | |
| Drug | N-heptylformamide | 2.32e-08 | 8 | 99 | 4 | CID000347402 | |
| Drug | 2-NA | 4.17e-08 | 9 | 99 | 4 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 4.17e-08 | 9 | 99 | 4 | CID000440672 | |
| Drug | 4-Iodopyrazole | 7.97e-08 | 3 | 99 | 3 | DB02721 | |
| Drug | AC1L1J0I | 1.62e-07 | 12 | 99 | 4 | CID000030201 | |
| Drug | 2-naphthaldehyde | 2.33e-07 | 13 | 99 | 4 | CID000006201 | |
| Drug | Fomepizole | 3.18e-07 | 4 | 99 | 3 | DB01213 | |
| Drug | naphthalenemethanol | 3.26e-07 | 14 | 99 | 4 | CID000020908 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 4.42e-07 | 15 | 99 | 4 | CID000440673 | |
| Drug | naphthaldehyde | 5.88e-07 | 16 | 99 | 4 | CID000006195 | |
| Drug | N-1-methylheptylformamide | 7.92e-07 | 5 | 99 | 3 | CID005478865 | |
| Drug | Ethylene Glycol | 1.90e-06 | 21 | 99 | 4 | ctd:D019855 | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.57e-06 | 199 | 99 | 8 | 7020_DN | |
| Drug | genistein; Up 200; 1uM; MCF7; HG-U133A | 2.57e-06 | 199 | 99 | 8 | 268_UP | |
| Drug | Ethanol | 2.76e-06 | 7 | 99 | 3 | DB00898 | |
| Drug | fomepizole | 5.47e-06 | 27 | 99 | 4 | ctd:C010238 | |
| Drug | dhmal | 7.35e-06 | 29 | 99 | 4 | CID000151725 | |
| Drug | AC1L1AOQ | 8.45e-06 | 30 | 99 | 4 | CID000001082 | |
| Drug | willardine | 1.10e-05 | 32 | 99 | 4 | CID000005123 | |
| Drug | walrycin A | 1.10e-05 | 32 | 99 | 4 | ctd:C574123 | |
| Drug | DOPEG | 1.78e-05 | 36 | 99 | 4 | CID000091528 | |
| Drug | CHEMBL83995 | 1.87e-05 | 2 | 99 | 2 | CID009571169 | |
| Drug | 3-methylbutanal | 2.21e-05 | 13 | 99 | 3 | CID000011552 | |
| Drug | 2-Propanol | 2.46e-05 | 39 | 99 | 4 | ctd:D019840 | |
| Drug | ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.48e-05 | 197 | 99 | 7 | 882_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 6983_DN | |
| Drug | Nicotinamide-Adenine-Dinucleotide | 2.73e-05 | 40 | 99 | 4 | DB01907 | |
| Drug | Nystatine [1400-61-9]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 2.73e-05 | 200 | 99 | 7 | 4807_DN | |
| Drug | Spiro Compounds | 2.80e-05 | 14 | 99 | 3 | ctd:D013141 | |
| Drug | benzyl alcohol | 3.12e-05 | 83 | 99 | 5 | CID000000244 | |
| Drug | zoxazolamine | 3.99e-05 | 44 | 99 | 4 | CID000006103 | |
| Drug | phenoxyethanol | 4.29e-05 | 16 | 99 | 3 | CID000031236 | |
| Drug | C x F | 7.35e-05 | 19 | 99 | 3 | CID000013017 | |
| Drug | Peony | 8.62e-05 | 20 | 99 | 3 | CID005483934 | |
| Drug | 4-iodopyrazole | 1.00e-04 | 21 | 99 | 3 | CID000077022 | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.21e-04 | 176 | 99 | 6 | 958_DN | |
| Drug | 2-butoxyethanol | 1.51e-04 | 24 | 99 | 3 | CID000008133 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 6.14e-06 | 37 | 95 | 4 | EFO_0007645, EFO_0009458 | |
| Disease | Pharyngeal Neoplasms | 1.03e-05 | 2 | 95 | 2 | C0031347 | |
| Disease | Malignant neoplasm of larynx | 1.03e-05 | 2 | 95 | 2 | C0007107 | |
| Disease | Malignant neoplasm of pharynx | 1.03e-05 | 2 | 95 | 2 | C0153405 | |
| Disease | Laryngeal neoplasm | 1.03e-05 | 2 | 95 | 2 | C0023055 | |
| Disease | alcohol dependence | 2.88e-05 | 183 | 95 | 6 | MONDO_0007079 | |
| Disease | alcohol dependence measurement | 3.03e-05 | 55 | 95 | 4 | EFO_0007835 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 6.23e-05 | 24 | 95 | 3 | EFO_0009458, MONDO_0007079 | |
| Disease | bitter alcoholic beverage consumption measurement | 7.22e-05 | 133 | 95 | 5 | EFO_0010092 | |
| Disease | Alcohol dependence | 1.02e-04 | 5 | 95 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 1.02e-04 | 5 | 95 | 2 | 103780 | |
| Disease | vitamin D measurement | 1.09e-04 | 336 | 95 | 7 | EFO_0004631 | |
| Disease | Aicardi-Goutieres Syndrome 2 | 1.53e-04 | 6 | 95 | 2 | C3489724 | |
| Disease | Aicardi Goutieres syndrome | 1.53e-04 | 6 | 95 | 2 | cv:C0393591 | |
| Disease | AICARDI-GOUTIERES SYNDROME 1 | 1.53e-04 | 6 | 95 | 2 | C0796126 | |
| Disease | Paroxysmal atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 1.72e-04 | 160 | 95 | 5 | C0004238 | |
| Disease | alcohol consumption measurement | RFX6 PKD1L3 ADH1A ADH1B ADH1C ADH7 LRPPRC CNTNAP5 CSTF3 CDK5RAP2 AKAP11 MYH16 WWC1 | 1.73e-04 | 1242 | 95 | 13 | EFO_0007878 |
| Disease | atrial fibrillation | 2.01e-04 | 371 | 95 | 7 | EFO_0000275 | |
| Disease | Pseudo-TORCH syndrome | 2.13e-04 | 7 | 95 | 2 | C3489725 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 2.13e-04 | 7 | 95 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | AICARDI-GOUTIERES SYNDROME | 2.84e-04 | 8 | 95 | 2 | C0393591 | |
| Disease | Anorectal Malformations | 3.15e-04 | 41 | 95 | 3 | C3495676 | |
| Disease | liver fat measurement | 3.63e-04 | 43 | 95 | 3 | EFO_0010821 | |
| Disease | Aicardi-Goutieres syndrome (is_implicated_in) | 3.64e-04 | 9 | 95 | 2 | DOID:0050629 (is_implicated_in) | |
| Disease | oropharynx cancer | 4.44e-04 | 46 | 95 | 3 | EFO_1001931 | |
| Disease | Facies | 4.54e-04 | 10 | 95 | 2 | C0282631 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 5.54e-04 | 11 | 95 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | Intellectual Disability | 6.14e-04 | 447 | 95 | 7 | C3714756 | |
| Disease | sugar consumption measurement | 6.23e-04 | 120 | 95 | 4 | EFO_0010158 | |
| Disease | Mouth Neoplasms | 7.12e-04 | 54 | 95 | 3 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 7.12e-04 | 54 | 95 | 3 | C0153381 | |
| Disease | isoleucine measurement | 7.92e-04 | 56 | 95 | 3 | EFO_0009793 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 7.92e-04 | 56 | 95 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Prostatic Neoplasms | 8.53e-04 | 616 | 95 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.53e-04 | 616 | 95 | 8 | C0376358 | |
| Disease | fibrinogen measurement, factor VII measurement | 8.77e-04 | 58 | 95 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 9.10e-04 | 14 | 95 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | IGF-1 measurement | 1.02e-03 | 488 | 95 | 7 | EFO_0004627 | |
| Disease | alcohol use disorder (is_implicated_in) | 1.20e-03 | 16 | 95 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | high altitude adaptation | 1.35e-03 | 17 | 95 | 2 | EFO_0009105 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 1.35e-03 | 17 | 95 | 2 | cv:C0270914 | |
| Disease | apolipoprotein B measurement | 1.36e-03 | 663 | 95 | 8 | EFO_0004615 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.45e-03 | 69 | 95 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Non-alcoholic Fatty Liver Disease | 1.51e-03 | 70 | 95 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.51e-03 | 70 | 95 | 3 | C3241937 | |
| Disease | drug-Induced dyskinesia, response to levodopa | 1.52e-03 | 18 | 95 | 2 | EFO_0010747, EFO_1000904 | |
| Disease | alkaline phosphatase measurement | ERN1 NOC2L RPS6KA3 U2SURP RRBP1 PKD1L3 FHIP2A ADH1B ADH1C ADH7 | 1.60e-03 | 1015 | 95 | 10 | EFO_0004533 |
| Disease | apolipoprotein A 1 measurement | 1.66e-03 | 848 | 95 | 9 | EFO_0004614 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 2.07e-03 | 21 | 95 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | Hepatitis | 2.27e-03 | 22 | 95 | 2 | HP_0012115 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.38e-03 | 566 | 95 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | body weight | AARS1 COPB1 TNRC6B PARD3B CHD8 ADH1B TNNI3K ASXL3 DGKK TLN2 CCDC171 | 2.43e-03 | 1261 | 95 | 11 | EFO_0004338 |
| Disease | Ovarian Serous Adenocarcinoma | 2.48e-03 | 23 | 95 | 2 | C1335177 | |
| Disease | parental emotion expression measurmement, conduct disorder | 2.93e-03 | 25 | 95 | 2 | EFO_0004216, EFO_0008342 | |
| Disease | serum albumin measurement | 3.05e-03 | 592 | 95 | 7 | EFO_0004535 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNKDKFEKAMAVGAT | 236 | P40394 | |
| KTFDLLNKNKTGMAV | 646 | Q8IYS0 | |
| GSGKLNKDAFAQLMK | 1336 | Q8NDM7 | |
| KMKIFQSFDSGKLLT | 2156 | Q96N23 | |
| TKAEKQAAMSKALGF | 301 | O75366 | |
| EMFDKASLKLGLDKA | 1266 | Q9HCK8 | |
| KLVADFMAKKFSLDA | 331 | P07327 | |
| KLVADFMAKKFSLDA | 331 | P00325 | |
| KLVADFMAKKFSLDA | 331 | P00326 | |
| LIGAAKNSFAKLMDK | 901 | Q6TFL3 | |
| NLFGKMADILEKIKN | 311 | Q6IC98 | |
| NKSLMIKDSIQKFAA | 541 | Q9UKA4 | |
| MAKTFRNLSKDGKGL | 641 | Q6MZZ7 | |
| RMAIESAGFKLNKKL | 641 | P07384 | |
| NEMKEQLKAFALKSA | 2106 | Q9C0F0 | |
| EDMGLKAFTNSKIRK | 671 | P01023 | |
| ALNAMLIKGSRDKQK | 1461 | Q96SN8 | |
| KAVFKGRDQKLMDSA | 1066 | Q68CQ1 | |
| NTANKKMLKDAFSLL | 641 | Q96S59 | |
| MKKDFAAKARLELLG | 191 | Q9HCJ3 | |
| FKNLLEAGKALKGMN | 161 | Q9NW13 | |
| QVVKLLAKMFGAKDS | 291 | Q9NTI5 | |
| NDLKNAMASFLPKKV | 306 | Q9H8K7 | |
| KKLQMAEKLGAAAGF | 176 | Q53FA7 | |
| LLDKYMKNSDASKAA | 551 | Q8HWS3 | |
| MDFAISKLKKAGNQT | 406 | O60674 | |
| LLGTINAKMKAFKKE | 871 | Q9Y4B5 | |
| LGKMSFTEKNLKALL | 391 | P0C860 | |
| MAFKGTKKRSQLDLE | 106 | O75439 | |
| MGFGSNKNAKKIKID | 371 | Q8TEW8 | |
| ALQSALDAMNKEFKK | 1176 | Q5KSL6 | |
| LMSDALILAKSKGFD | 436 | O60551 | |
| DLMENKTFLEKLKFG | 456 | O60551 | |
| KKVLTSFGDAIKNMD | 66 | P02100 | |
| IKNMDNLKPAFAKLS | 76 | P02100 | |
| GFQTLKKIDKKMSDA | 191 | Q8IX03 | |
| KKISGSDARQLYAMK | 86 | P51812 | |
| EMKALNDKFASLIGK | 86 | Q6KB66 | |
| MALSLGDKINLSQKK | 936 | P53618 | |
| KLLAEKGDMNNAKLF | 306 | Q12996 | |
| KLGFKESLVQSKMAA | 131 | Q96KR6 | |
| LFMGKLEKAQAKTSR | 251 | Q8TE67 | |
| SSLSFFLKKMGKRLD | 151 | Q8N4B4 | |
| ILGKMSFSEKNLKAL | 466 | Q8N5Y2 | |
| AMKGKRKTLNASDVL | 56 | Q9NRF9 | |
| FLDARFKTMKKDSLN | 511 | Q9UIQ6 | |
| DQKLKFLRLMGGFKN | 371 | Q1ED39 | |
| LANKTDLAKALMKAV | 416 | P42704 | |
| AFMDGSNRKDLVKTK | 541 | P98164 | |
| GKSIKAFKESAKQML | 2036 | P46013 | |
| KLLFGKVAKDSSRML | 221 | Q9Y3T9 | |
| SMDKAAVKIQAAFKG | 4871 | Q5VST9 | |
| VFSNKFLAMSKKGKL | 136 | P12034 | |
| GLKMANEAAAKNRAK | 356 | Q96DF8 | |
| MDFSGLSLIKLKKQE | 966 | O75146 | |
| AGSKKVAKQDAAMKA | 551 | P55265 | |
| KAMISDFGLCKKLAV | 706 | O75460 | |
| TGILSMFAAKAGAKK | 266 | O60678 | |
| EMFDKASLKLGLDKA | 916 | Q8TD26 | |
| LKNLGKAMGAKVNDF | 51 | A1L170 | |
| KKMDALLQAASLGKL | 431 | Q8NCU4 | |
| AALEGIKNALASKML | 101 | O00458 | |
| KETVGFGMLKAKAQA | 96 | Q9Y2Q5 | |
| YNKGKTALLSAAKVM | 666 | Q9Y4D2 | |
| KLKQDGDSFRMKLNT | 681 | Q14204 | |
| SEMLSLFEKGLKNVK | 86 | Q9UKA1 | |
| KMDLASLCLKAGVKN | 2861 | Q9NYC9 | |
| FFLENKMKSLASKGV | 171 | Q5W0V3 | |
| FSEGFLEAKTLAKKM | 1971 | Q8IVF4 | |
| KYTQAGNKLKAMRAL | 1211 | Q96RY7 | |
| GNKLKAMRALLKSGD | 1216 | Q96RY7 | |
| LKDVISLKFKSMQGD | 201 | Q8WYK1 | |
| LMANVKKAFIGENKD | 436 | Q9HC10 | |
| AINARKMKFALLKGS | 361 | Q15084 | |
| KMKFALLKGSFSEQG | 366 | Q15084 | |
| KALDTMNFDIIKGKS | 66 | P0CB38 | |
| MAKASAAELKVFKSG | 56 | Q8NEY1 | |
| DNYALSKKGVKAMSL | 186 | Q8N461 | |
| GMLSRALKDSKKFFS | 86 | C9JL84 | |
| LELMKKAASKGLHQA | 751 | Q68CR1 | |
| MFKGKRGAQLAKDIA | 161 | P09661 | |
| QKSMLEKLKLFNSKG | 421 | Q8IVL1 | |
| MAFGKERKSLKKEAA | 1676 | Q7Z443 | |
| FLFDMATGKLTKAKR | 331 | Q9H1Z4 | |
| GEMFKLRAADAKEKQ | 146 | Q9BXB5 | |
| QNMDLGFKLLKKLAF | 51 | Q8IW75 | |
| LLENKLKAFSIGKMS | 76 | O15042 | |
| LNKEMAAEKAKAAAG | 726 | Q9P2E9 | |
| KALTASKGKLFFGMQ | 391 | Q96T58 | |
| ASAKALNEALKLFKM | 866 | P49588 | |
| AAQKALAKVDKSGMK | 281 | Q5TBB1 | |
| EFLNMLLDKGAVKTK | 401 | Q8IX01 | |
| LKIADLMQFDDKGNK | 201 | Q14CB8 | |
| SGKLISLFQAMKKGL | 4156 | Q15149 | |
| KLGELQSAYDGAKKM | 1556 | Q8IUG5 | |
| AAAALDKKQRLFDKM | 601 | Q9H6N6 | |
| KGGSKLLRMKLSDFN | 3646 | P78527 | |
| KAVANAAAMLVLKAK | 676 | Q9Y4G6 | |
| LASAKGFLNIAKLLM | 206 | Q59H18 | |
| MKLAFKSLDKNNDGK | 91 | Q6NUK1 | |
| AKNFITKMAKEGAAE | 826 | Q9NYU2 | |
| GRMFKQFNKLTEDKA | 766 | Q13263 | |
| SDKKFDVDKRAMNLG | 1091 | Q9UPQ9 | |
| KFLMSRAKDGFLEKL | 616 | Q9P1Q0 | |
| KANLKLALDAMKDLA | 351 | Q9UKW4 |